Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 17;2014(1):CD008298.
doi: 10.1002/14651858.CD008298.pub3.

Physical health care monitoring for people with serious mental illness

Graeme Tosh  1 , Andrew V Clifton, Jun Xia, Margueritte M White
Affiliations

Physical health care monitoring for people with serious mental illness

Graeme Tosh et al. Cochrane Database Syst Rev. .

Abstract

Background: Current guidance suggests that we should monitor the physical health of people with serious mental illness, and there has been a significant financial investment over recent years to provide this.

Objectives: To assess the effectiveness of physical health monitoring, compared with standard care for people with serious mental illness.

Search methods: We searched the Cochrane Schizophrenia Group Trials Register (October 2009, update in October 2012), which is based on regular searches of CINAHL, EMBASE, MEDLINE and PsycINFO.

Selection criteria: All randomised clinical trials focusing on physical health monitoring versus standard care, or comparing i) self monitoring versus monitoring by a healthcare professional; ii) simple versus complex monitoring; iii) specific versus non-specific checks; iv) once only versus regular checks; or v) different guidance materials.

Data collection and analysis: Initially, review authors (GT, AC, SM) independently screened the search results and identified three studies as possibly fulfilling the review's criteria. On examination, however, all three were subsequently excluded. Forty-two additional citations were identified in October 2012 and screened by two review authors (JX and MW), 11 of which underwent full screening.

Main results: No relevant randomised trials which assess the effectiveness of physical health monitoring in people with serious mental illness have been completed. We identified one ongoing study.

Authors' conclusions: There is still no evidence from randomised trials to support or refute current guidance and practice. Guidance and practice are based on expert consensus, clinical experience and good intentions rather than high quality evidence.

PubMed Disclaimer

Conflict of interest statement

Graeme Tosh and Andrew Clifton are involved in the trial identified as ongoing in this review.

All other authors have no conflict of interest.

Figures

1
1
Study flow diagram for 2012 update. .
See this image and copyright information in PMC

Update of

References

References to studies excluded from this review

Becker 2005 {published data only}
    1. Becker T. Outcome monitoring and outcome management in inpatient psychiatric care (Ergebnis‐Monitoring und Ergebnis‐Management in der stationären psychiatrischen Versorgung). http://www.controlled‐trials.com 2005.
Bushe 2010 {published data only}
    1. Bushe C, Sniadecki J, Bradley AJ, Poole Hoffmann V. Comparison of metabolic and prolactin variables from a six‐month randomised trial of olanzapine and quetiapine in schizophrenia. Journal of Psychopharmacology 2010;24(7):1001‐9. - PubMed
Carmeli 2012 {published data only}
    1. Carmeli C, Knyazeva MG, Cuenod M, Do KQ. Glutathione precursor n‐acetyl‐cysteine modulates eeg synchronization in schizophrenia patients: A double‐blind, randomized, placebo‐controlled trial. PLoS ONE 2012; Vol. 7, issue 2. - PMC - PubMed
Jürgens 2008 {published data only}
    1. Jürgens G, Nordentoft M. Effect of genotyping for cyp450 polymorphisms versus intense clinical monitoring on antipsychotic drug treatment. http://www.clinicaltrials.gov 2008.
Kluge 2012 {published data only}
    1. Kluge M, Himmerich H, Wehmeier PM, Rummel‐Kluge C, Dalal M, Hinze‐Selch D, et al. Sleep propensity at daytime as assessed by multiple sleep latency tests (mslt) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research 2012;135(1‐3):123‐7. - PubMed
Krakowski 2011 {published data only}
    1. Krakowski M, Czobor P. Cholesterol and cognition in schizophrenia: A double‐blind study of patients randomized to clozapine, olanzapine and haloperidol. Schizophrenia Research 2011;130(1‐3):27‐33. - PubMed
Lan 2007 {published data only}
    1. Lan T‐H, Chiu H‐J. The monitor of serum prolactin level and related clinical observations among individuals with schizophrenia spectrum illnesses in a 3 months aripiprazole trial. http://www.clinicaltrials.gov 2007.
Lin 2010 {published data only}
    1. 林素兰, 张实秋, 林贵兰. health education intervention on the impact of schizophrenia patients with constipation] Google Translate [健康教育干预对精神分裂症病人便秘影响的研究 []. 全科护理 2010; Vol. 8, issue 7C:1891‐3.
Nielsen 2012 {published data only}
    1. Nielsen J, Thode D, Stenager E, Andersen KO, Sondrup U, Hansen TN, et al. Hematological clozapine monitoring with a point‐of‐care device: A randomized cross‐over trial. European Neuropsychopharmacology 2012;22(6):401‐5. [MEDLINE: ] - PubMed
Ozguven 2011 {published data only}
    1. Ozguven HD, Baskak B, Oner O, Atbasoglu C. Metabolic effects of olanzapine and quetiapine: A six‐week randomized, single blind, controlled study. Open Neuropsychopharmacology Journal 2011;4(1):10‐7.
Peuskens 2011 {published data only}
    1. Hert M, Mittoux A, He Y, Peuskens J. Metabolic parameters in the short‐ and long‐term treatment of schizophrenia with sertindole or risperidone. European Archives of Psychiatry and Clinical Neuroscience 2011;261(4):231‐9. [MEDLINE: ] - PubMed
Rostow 1980 {published data only}
    1. Rostow CD. The effect of self vs. external monitoring and locus of control upon the pacing and general adjustment of psychiatric inpatients. Behaviour Research and Therapy 1980;18(6):541‐8. [MEDLINE: ] - PubMed
Saddichha 2011 {published data only}
    1. Saddichha S, Akhtar S. Hypertension, diabetes and cardiometabolic changes associated with antipsychotic use in schizophrenia. International Clinical Psychopharmacology 2011;26:143.
Strom 2011 {published data only}
    1. Strom BL, Eng SM, Faich G, Reynolds RF, D'Agostino RB, Ruskin J, et al. The Ziprasidone Observational Study of Cardiac outcomes (ZODIAC): findings from a large simple trial of ziprasidone vs. Olanzapine in real‐world use among 18154 patients with schizophrenia. Schizophrenia Research 2010;117(2‐3):311.
Tanasiewicz 2011 {published data only}
    1. Tanasiewicz M, Skucha‐Nowak M, Greñ A, Hese RT, Twardawa H, Gorczyca P. Analysis of state of the oral cavity in schizophrenic inpatients treated with atypical and classical neuroleptics [Analiza stanu jamy ustnej chorych na schizofreniê leczonych psychiatrycznie w warunkach szpitalnych neuroleptykami atypowymi i klasycznymi]. Advances in Clinical and Experimental Medicine 2011;20(2):187‐98.

References to ongoing studies

ISRCTN63382258 {published data only}
    1. Jones HF, Adams CE, Clifton A, Simpson J, Tosh G, Liddle PF, et al. An oral health intervention for people with serious mental illness (Three Shires Early Intervention Dental Trial): study protocol for a randomised controlled trial. Trials 2013;14(1):158. - PMC - PubMed

Additional references

Adams 1856
    1. Adams F. The Book of Cures In: The extant works of Aretaeus, the Cappadocian. 1st Edition. London: The Sydenham Society, 1856.
Altman 1996
    1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200. - PMC - PubMed
Ammer 2003
    1. Ammer C. The American Heritage Dictionary of Idioms. http://www.yourdictionary.com/about/The‐American‐Heritage‐Dictionary‐of‐... (accessed 23 December 2009).
Asenjo 2010
    1. Asenjo LC, Komossa K, Rummel‐Kluge C, Hunger H, Schmid F, Schwarz S, et al. Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2010, issue 11. [DOI: 10.1002/14651858.CD006633.pub2; CD006633] - DOI - PMC - PubMed
Bayles 2009
    1. Bayles B, Usatine R. Evening primrose oil. American Family Physician 2009;80(12):1405‐8. - PubMed
Bland 1997
    1. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600. - PMC - PubMed
Boissel 1999
    1. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite.]. Therapie 1999;54(4):405‐11. [PUBMED: 10667106] - PubMed
Bradshaw 2005
    1. Bradshaw T, Lovell K, Harris N. Healthy living interventions and schizophrenia: a systematic review. Journal of Advanced Nursing 2005;49(6):634‐54. - PubMed
Brown 2010
    1. Brown S, Kim M, Mitchell C, Inskip H. Twenty‐five year mortality of a community cohort with schizophrenia. British Journal of Psychiatry 2010;196:116‐21. - PMC - PubMed
BSDH 2000
    1. British Society for Disability and Oral Health (Working Group). Oral health care for people with mental health problems ‐ guidelines and recommendations. http://www.bsdh.org.uk/guidelines/mental.pdf (accessed 23 December 2009):1‐20.
Burns 1998
    1. Burns T, Cohen A. Item‐of‐service payments for general practitioner care of severely mentally ill persons: does the money matter?. British Journal of General Practice 1998;48(432):1415‐6. [PUBMED: 9800401] - PMC - PubMed
Cooper 2003
    1. Cooper B. Evidence‐based mental health policy: a critical appraisal. British Journal of Psychiatry 2003;183:105‐13. - PubMed
Cournos 2005
    1. Cournos F, McKinnon K, Sullivan G. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus. Journal of Clinical Psychiatry 2005;66 Suppl 6:27‐33. [PUBMED: 16107181] - PubMed
Deeks 2000
    1. Deeks J. Issues in the selection for meta‐analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape town. Cape Town: The Cochrane Collaboration, 2000.
Divine 1992
    1. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623‐9. - PubMed
Dixon 1999
    1. Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 1999;187(8):496‐502. [PUBMED: 10463067] - PubMed
DoH 2006
    1. Department of Health. Choosing Health: Supporting the physical needs of people with severe mental illness. www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/d... (accessed 5 November 2009).
Donner 2002
    1. Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971‐80. - PubMed
Egger 1997
    1. Egger M, Davey‐Smith G, Schneider M, Minder CSO. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;13:629‐34. - PMC - PubMed
El‐Hai 2008
    1. El‐Hai J. Lessons of the first era of psychosurgery. Clinical Neurosurgery 2008;55:138‐9. [PUBMED: 19248679] - PubMed
Elbourne 2002
    1. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9. - PubMed
Essali 2009
    1. Essali A, Al‐Haj HN, Li C, Rathbone J. Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2009, issue 1. [DOI: 10.1002/14651858.CD000059.pub2; CD000059] - DOI - PMC - PubMed
Furukawa 2006
    1. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(7):7‐10. - PubMed
Gulliford 1999
    1. Gulliford MC. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org..
Hutton 2009
    1. Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27‐30. - PubMed
JAMA 1925
    1. Bureau of Investigation, Journal of the American Medical Association. Radium ore revigorator: Capitalizing the public's ignorance of radium and radioactivity. Journal of the American Medical Association 1925;85:1658‐60.
Kay 1986
    1. Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS) manual. North Tonawanda, NY: Multi‐Health Systems, 1986.
Khanna 2012
    1. Khanna P, Clifton A, Banks D, Tosh G. Smoking cessation advice for people with serious mental illness. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 3. [DOI: 10.1002/14651858.CD009704; CD009704] - DOI - PMC - PubMed
Khokhar 2011
    1. Khokhar WA, Clifton A, Jones H, Tosh G. Oral health advice for people with serious mental illness. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011, issue 11. [DOI: 10.1002/14651858.CD008802.pub2; CD008802] - DOI - PubMed
Komossa 2009
    1. Komossa K, Rummel‐Kluge C, Hunger H, Schwarz S, Schmid F, Lewis R, et al. Sertindole versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2009, issue 2. [DOI: 10.1002/14651858.CD006752.pub2; CD006752] - DOI - PMC - PubMed
Komossa 2010
    1. Komossa K, Rummel‐Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, et al. Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2010, issue 3. [DOI: 10.1002/14651858.CD006654.pub2; CD006654] - DOI - PMC - PubMed
Leucht 2005
    1. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 2005;187:366‐71. [PUBMED: 16199797] - PubMed
Leucht 2005a
    1. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2‐3):231‐8. [PUBMED: 15982856] - PubMed
Leucht 2007
    1. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183‐91. [PUBMED: 16905632] - PMC - PubMed
Ley 2000
    1. Ley A, Jeffery DP, McLaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD001088] - DOI - PubMed
Marder 2004
    1. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 2004;161(8):1334‐49. - PubMed
Marshall 1996
    1. Marshall M. Case management: a dubious practice: Underevaluated and ineffective, but now government policy. BMJ 1996;312:523‐4. - PMC - PubMed
Marshall 1998
    1. Marshall M, Gray A, Lockwood A, Green R. Case management for people with severe mental disorders. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000050] - DOI - PubMed
Marshall 2000
    1. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249‐52. [PUBMED: 10755072] - PubMed
Newman 1991
    1. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Canadian Journal of Psychiatry 1991;36(4):239‐45. [PUBMED: 1868416] - PubMed
NICE 2006
    1. National Collaborating Centre for Mental Health. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline Number 38. The British Psychological Society and Gaskell, 2006. - PubMed
NIMH 1987
    1. National Institute of Mental Health. Towards a model for a comprehensive community‐based mental health system. National Institute of Mental Health Washington, DC: NIMH. 1987.
Overall 1962
    1. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799‐812.
Paton 2004
    1. Paton C, Esop R, Young C, Taylor D. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica 2004;110(4):299‐305. [PUBMED: 15352932] - PubMed
RCPsych 2009
    1. Phelan M. Physical health standards: the West London Mental Health Trust. Physical Health in Mental Health: Occasional Paper 67. Royal College of Psychiatrists, 2009:21‐23.
RCPsych 2009a
    1. Osbourne D, Phelan M. Psychotropic prescribing. Physical Health in Mental Health: Occasional Paper 67. Royal College of Psychiatrists, 2009:55‐61.
Robson 2007
    1. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies 2007;44(3):457‐66. [PUBMED: 17007859] - PubMed
Ruggeri 2000
    1. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. Definition and prevalence of severe and persistent mental illness. British Journal of Psychiatry 2000;177:149‐55. [PUBMED: 11026955] - PubMed
Schinnar 1990
    1. Schinnar AP, Rothbard AB, Kanter R, Jung YS. An empirical literature review of definitions of severe and persistent mental illness. American Journal of Psychiatry 1990;147(12):1602‐8. [PUBMED: 2244636] - PubMed
Schünemann 2008
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359‐83.
Tanenbaum 2005
    1. Tanenbaum SJ. Evidence‐based practice as mental health policy: Three controversies and a caveat. Health Affairs 2005;24(1):163‐73. - PubMed
Taylor 2009
    1. Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines. 10th Edition. Informa Healthcare, 2009.
Tosh 2011
    1. Tosh G, Clifton A, Bachner M. General physical health advice for people with serious mental illness. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011, issue 2. [DOI: 10.1002/14651858.CD008567.pub2; CD008567] - DOI - PubMed
Tosh 2013
    1. Tosh G, Gray R, Mala S, Clifton A, Bachner M. General physical health advice for people with serious mental illness. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD008567.pub2] - DOI - PubMed
Ukoumunne 1999
    1. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area‐wide and organistation‐based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1‐75. - PubMed
Weinmann 2009
    1. Weinmann S, Read J, Aderhold V. Influence of antipsychotics on mortality in schizophrenia: systematic review. Schizophrenia Research 2009;113(1):1‐11. [PUBMED: 19524406] - PubMed
White 2009
    1. White J, Gray R, Jones M. The development of the serious mental illness physical health improvement profile. Journal of Psychiatric and Mental Health Nursing 2009;16(5):493‐8. [PUBMED: 19538607] - PubMed
WHO 1948
    1. World Health Organization. WHO definition of Health [Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York]. Official records of the World Health Organization. New York, 1948; Vol. 2:100.
Wright 2012
    1. Wright N, Akhtar A, Tosh G, Clifton A. HIV prevention advice for people with serious mental illness. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 2. [DOI: 10.1002/14651858.CD009639; CD009639] - DOI
Xia 2009
    1. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El‐Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254‐7.

Publication types